shop
Investors
View our Gastro-Mint® product for the relief of symptoms of medically diagnosed Irritable Bowel Syndrome.
May 26, 2025
AFT Pharmaceuticals (NZX:AFT, ASX:AFP) today announces it has extended its US Maxigesic® licensing agreement with Hikma Pharmaceuticals….